Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ZS Pharma
ZS Pharma
FDA document lays out issues undermining approval of AstraZeneca's ZS Pharma drug
Fierce Pharma
Wed, 04/19/17 - 04:12 pm
FDA
AstraZeneca
ZS-9
ZS Pharma
hyperkalemia
AstraZeneca Remains Committed To Development Of ZS-9 Despite Letter From FDA
Yahoo/Benzinga
Fri, 05/27/16 - 12:42 pm
AstraZeneca
FDA
ZS-9
hyperkalaemia
ZS Pharma
ZS Pharma Announces New Employment Inducement Grants
Yahoo
Wed, 11/11/15 - 10:02 am
ZS Pharma
One Reason We Think Biotech Has Bottomed
Seeking Alpha
Sun, 11/8/15 - 11:49 am
biotech
Allergan
AstraZeneca
Bristol-Myers Squibb
Celgene
Gilead Sciences
Horizon Pharma
Insys
Pfizer
Retrophin
Valeant Pharmaceuticals
ZS Pharma
5 BioPharma Movers That Cannot Be Ignored
24/7 Wall St
Sat, 11/7/15 - 11:38 am
MannKind
ZS Pharma
Xoma
Dyax
Valeant Pharmaceuticals
AstraZeneca agrees to buy ZS Pharma for $2.7 billion
Yahoo/Reuters
Fri, 11/6/15 - 10:43 am
AstraZeneca
ZS Pharma
M&A
Actelion: We're interested in ZS Pharma, but not dependent on M&A
BioPharma Dive
Thu, 10/22/15 - 09:48 am
Actelion
ZS Pharma
M&A
10 Best Nasdaq Biotech Stocks in the Third Quarter
TheStreet.com
Wed, 09/30/15 - 07:49 pm
Incyte
Myriad
Cara Therapeutics
Sucampo
ZS Pharma
Concert Pharmaceuticals
The Medicines Company
Lexicon Pharmaceuticals
Exelixis
Anacor
Actelion and ZS Pharma confirm acquisition talks
Marketwatch
Fri, 09/11/15 - 09:52 am
Actelion
ZS Pharma
IPO Stock Watch: Biotech ZS Pharma Hits New High
Investors.com
Sat, 02/21/15 - 09:40 am
ZS Pharma
Encouraging Results For Two New Drugs That Fight A Common And Dangerous Side Effect
Forbes
Fri, 11/21/14 - 03:10 pm
RAAS
ZS Pharma
hyperkalemia
ZS-9
Relypsa
2014's most successful biotech IPOs
Fierce Biotech
Mon, 10/13/14 - 08:03 am
IPOs
biotech
Ultragenyx
ZS Pharma
Auspex Pharmaceuticals
Avalanche Biotechnologies
SAGE Therapeutics
Kite Pharma
Otonomy
Zafgen
ProQR
Radius Health
ZS Pharma begins enrollment in phase 3 study of ZS-9 in Hyperkalemia patients
Pharmabiz
Sat, 06/28/14 - 11:49 am
hyperkalemia
ZS Pharma
ZS-9
IPO Preview: ZS Pharma
Seeking Alpha
Wed, 06/18/14 - 04:25 am
IPOs
ZS Pharma